Vertex Pharmaceuticals VRTX
NASDAQ VRTX
$538.60 -4.02 (-0.74%)
At close: Nov 13, 2026 · 4:00 PM EST

Vertex Pharmaceuticals (VRTX) Asset Writedowns and Impairment (2009 - 2025)

Updated

Analysis

Vertex Pharmaceuticals (VRTX) Asset Writedowns and Impairment (2009 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn
10 Vertex Pharmaceuticals 136.55 Bn 104.28 Bn 2.91 Bn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 379.00 Mn
Dec 31, 2019 -8.65 Mn
Sep 30, 2019 1.61 Mn
Jun 30, 2019 5.77 Mn
Mar 31, 2019 1.27 Mn
Dec 31, 2018 15.91 Mn
Sep 30, 2017 255.34 Mn
Dec 31, 2015 2.49 Mn
Dec 31, 2014 711,000.00
Dec 31, 2013 250.60 Mn
Mar 31, 2013 412.90 Mn
Sep 30, 2011 105.80 Mn
Dec 31, 2009 7.20 Mn
API Access

Vertex Pharmaceuticals Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=VRTX&period=max&api_key=YOUR_API_KEY